ChromaDex (CDXC) Misses Q1 EPS by 3c

ChromaDex (NASDAQ: CDXC) reported Q1 EPS of ($0.12), $0.03 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $14.3 million versus the consensus estimate of $16.68 million.

For earnings history and earnings-related data on ChromaDex (CDXC) click here.

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• Stay long AI-capex winners into the peak, Stifel says despite bubble fears
• Hertz cuts guidance, announces notes and stock offerings, shares sink